Llwytho...
Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia
Pure red cell aplasia (PRCA) due to neutralizing antibodies can rarely develop following treatment with epoetin. The treatment of this condition is generally unsatisfactory and immunosuppression is often recommended, which improves chances of hematological recovery. We describe a case of PRCA due to...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Indian J Nephrol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Medknow Publications & Media Pvt Ltd
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4663775/ https://ncbi.nlm.nih.gov/pubmed/26664213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-4065.156897 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|